Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025 17:42 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Feb.…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:01 ET | Source: Chimerix, Inc. DURHAM, N.C., Jan.…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:01 ET | Source: Chimerix, Inc. DURHAM, N.C., Jan.…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc.…
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass.,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc.…
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass.,…